Review on the Applications of Selected Metal-Based Complexes on Infectious Diseases
Open Access
Abstract
Fatalities caused by infectious diseases (i.e., diseases caused by parasite, bacteria, and viruses) have become reinstated as a major public health threat globally. Factors such as antimicrobial resistance and viral complications are the key contributors to the death numbers. As a result, new compounds with structural diversity classes are critical for controlling the virulence of pathogens that are multi-drug resistant. Derivatization of bio-active organic molecules with organometallic synthons is a promising strategy for modifying the inherent and enhanced properties of biomolecules. Due to their redox chemistry, bioactivity, and structural diversity, organometallic moieties make excellent candidates for lead structures in drug development. Furthermore, organometallic compounds open an array of potential in therapy that existing organic molecules lack, i.e., their ability to fulfill drug availability and resolve the frequent succumbing of organic molecules to drug resistance. Additionally, metal complexes have the potential towards metal-specific modes of action, preventing bacteria from developing resistance mechanisms. This review’s main contribution is to provide a thorough account of the biological efficacy (in vitro and in vitro) of metal-based complexes against infectious diseases. This resource can also be utilized in conjunction with corresponding journals on metal-based complexes investigated against infectious diseases.Keywords
Funding Information
- National Research Foundation (TTK2204295276)
- Tshwane University of Technology (TTK2204295276)
This publication has 58 references indexed in Scilit:
- Exploring the Versatility of Cycloplatinated Thiosemicarbazones as Antitumor and Antiparasitic AgentsOrganometallics, 2012
- Drug resistance in Mycobacterium tuberculosis clinical isolates from Brazil: Phenotypic and genotypic methodsBiomedicine & Pharmacotherapy, 2011
- Benzimidazol-2-ylidene Gold(I) Complexes Are Thioredoxin Reductase Inhibitors with Multiple Antitumor PropertiesJournal of Medicinal Chemistry, 2010
- Neglected Tropical Diseases: Multi-Target-Directed Ligands in the Search for Novel Lead Candidates against Trypanosoma and LeishmaniaJournal of Medicinal Chemistry, 2009
- Bioorganometallic chemistry—from teaching paradigms to medicinal applicationsChemical Society Reviews, 2008
- Paul Ehrlich's magic bullet concept: 100 years of progressNature Reviews Cancer, 2008
- Discovery and High-Throughput Screening of Heteroleptic Iridium Complexes for Photoinduced Hydrogen ProductionJournal of the American Chemical Society, 2005
- The challenge of emerging and re-emerging infectious diseasesNature, 2004
- New Luminescent Cyclometalated Iridium(III) Diimine Complexes as Biological Labeling ReagentsInorganic Chemistry, 2003
- Search for New Drugs for Treatment of TuberculosisAntimicrobial Agents and Chemotherapy, 2001